CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
immune response and demonstrate efficacy in patients with advanced triple-negative breast cancer.This study will ...
Phase 2
Swansea, Illinois, United States and 5 other locations
of durvalumab in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 46 other locations
neoadjuvant chemotherapy plus nivolumab in patients with early stage triple-negative breast cancer (TNBC) and imp...
Phase 1, Phase 2
Saint Louis, Missouri, United States
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Swansea, Illinois, United States and 216 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Saint Louis, Missouri, United States and 131 other locations
This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...
Phase 3
Saint Louis, Missouri, United States and 273 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Saint Louis, Missouri, United States and 357 other locations
This is a Phase III, randomised, open-label, 3-arm, multicentre, international study assessing the efficacy and safety of Dato-DXd with or without du...
Phase 3
Saint Louis, Missouri, United States and 275 other locations
(HCC), pancreatic ductal adenocarcinoma (PDAC), biliary tract cancers (BTC), esophageal squamous cell carcinoma (ESCC), triple negative...
Phase 1
Saint Louis, Missouri, United States and 26 other locations
A study evaluating the safety, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of ABBV-927 with ABBV-368, Budigalimab (ABBV-181) an...
Phase 1
Saint Louis, Missouri, United States and 25 other locations
Clinical trials
Research sites
Resources
Legal